Alcon Inc. (ALC)

Market Cap	42.04B -5.3%
Revenue (ttm)	10.40B +4.9%
Net Income	980.00M -3.7%
EPS	1.98 -3.4%
Shares Out	487.43M
PE Ratio	42.90
Forward PE	24.59
Dividend	$0.22 (0.25%)
Ex-Dividend Date	May 14, 2025

Volume	2,862,407
Open	87.55
Previous Close	86.27
Day's Range	85.92 - 87.64
52-Week Range	71.55 - 99.20
Beta	0.69
Analysts	Buy
Price Target	89.21 (+2.87%)
Earnings Date	Feb 24, 2026

About ALC

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company’s cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,942
• Stock Exchange: NYSE
• Ticker Symbol: ALC
• Website: https://www.alcon.com

Financial Performance

In 2025, Alcon's revenue was $10.40 billion, an increase of 4.94% compared to the previous year's $9.91 billion. Earnings were $980.00 million, a decrease of -3.73%.

Analyst Summary

According to 12 analysts, the average rating for ALC stock is "Buy." The 12-month stock price target is $89.21, which is an increase of 2.87% from the latest price.

Price Target

$89.21

(2.87% upside)

Analyst Consensus: Buy